Michigan Medicine 13th Annual Western Michigan Liver Round-Up 2024

New information regarding the medical evaluation of steatotic liver disease, how to evaluate a patient with a liver mass, and the diagnosis and management of patients with alcohol liver disease will be reviewed. In addition, an update on the detection and management of minimal hepatic encephalopathy, GI bleeding
in patients with cirrhosis, and how we can collectively increase the organ donor supply in Michigan will be provided.

Following the course, the participants will understand and be able to implement:
■ Latest developments in the diagnosis and treatment of steatotic liver disease including the use of diet and exercise, resmetlrom, GLP-1 agonists and bariatric endoscopy
■ Recommended approach to evaluating a patient with a liver mass
■ Approach to the diagnosis and treatment of patients with alcoholic liver disease with an emphasis on outpatient management
■ How to diagnose and treat patients with covert and overt hepatic encephalopathy
■ Recommended management of upper GI bleeding in patients with cirrhosis
■ Current efforts and outcomes to expand the organ donor pool in Michigan including the use of DCD livers

+ Topics:

Agenda.pdf
Detection and Treatment of Hepatic Encephalopathy.mp4
Diagnosis and Management of Alcohol Liver Disease.mp4
Evaluation of a Patient with a Liver Mass.mp4
Expanding the Organ Donor Pool in Michigan.mp4
Medical Management of GI Bleeding in Cirrhosis.mp4
Medical Management of Steatotic Liver Disease.mp4
Panel Question & Answers 1.mp4
Panel Question & Answers 2.mp4